HIGHLIGHTS
- who: Joel Rodru0131u0301guez-Saldau00f1a and collaborators from the Resultados Mu00e9dicos Desarrollo e Investigaciou0301n SC, Pachuca, Hidalgo, Mexico have published the Article: Real-World Evidence Evaluation on the Lipid Profile Therapeutic Goals and Safety of the Fixed-Dose Combination of Rosuvastatin/ Ezetimibe (Trezete ) in Dyslipidemia Patients, in the Journal: Cardiology Research and Practice of 10/09/2022
- what: The aim of the study was to evaluate changes in the lipid profile and the effect on therapeutic goals, as well as the safety of dyslipidemia patients treated with Rosuvastatin/Ezetimibe (Trezete ). At the end of the follow . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.